Extracellular vesicle-associated transcriptomic and proteomic biomarkers show in vitro potential for vandetanib treatment monitoring in anaplastic thyroid cancer.

Sci Rep · 2025 · PMC12432113 · PMID 40940449

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

AHNAK2 was significantly downregulated in the cfRNA at EC80 and GPRC5C showed consistent downregulation across all vandetanib doses in cfRNA compared to DMSO, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.